Trisomy 18 (Edwards Syndrome) (cont.)
IN THIS ARTICLE
Trisomy 18 Diagnosis
In newborns, chromosome analysis can be carried out to determine the exact cause of birth defects. Prenatal testing for trisomy 18 is possible.
Screening tests such as measurement of alpha fetoprotein (AFP) levels (sometimes referred to as a triple screen) is one screening test. The triple test screens the mother's blood for AFP, hCG (human chorionic gonadotropin, the so-called "pregnancy hormone"), and estriol (a type of estrogen). The test is performed between the 15th and 17th week of pregnancy. A positive result on a screening test does not mean that the baby will have trisomy 18 or any chromosomal abnormality. In fact, only about 11% of those women who receive a positive result for trisomy 18 in this test will actually have an affected fetus.
Ultrasound is another commonly used screening test. Like the AFP test, a simple ultrasound cannot be used to establish the diagnosis of trisomy 18. A more detailed ultrasound may be performed to look for the characteristic signs of trisomy 18, but it cannot confirm alone that trisomy 18 is present.
Analysis of fetal chromosomal material obtained during amniocentesis or chorionic villus sampling is necessary to prove that the additional copy of chromosome 18 is present. An amniocentesis is usually performed at 15-18 weeks of pregnancy and is the most commonly used test for the prenatal diagnosis of trisomy 18. During this procedure, a thin needle is inserted through the abdominal wall and a small sample of amniotic fluid is taken.
Chorionic villus sampling is another type of test that allows the examination of fetal genetic material. It is performed earlier in pregnancy (at 10-12 weeks after the last menstrual period) and therefore carries the advantage of allowing for an earlier diagnosis. This procedure involves the collection a chorionic villus cell sample from the placenta either through the insertion of a needle in the abdominal wall or through a catheter in the vagina.
Must Read Articles Related to Trisomy 18 (Edwards Syndrome)